ALPN 64.97 (+0%)
US02083G1004BiotechnologyBiotechnology

Alpine Immune Sciences (ALPN) Stock Highlights

64.97 | +0%
2024-12-21 02:24:56
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The companys proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202.

Statistics

Range Today
64.97 64.97
Volume Today 0
Range 1 Year
8.33 65
Volume 1 Year 255.12M
Range 3 Year
4.82 65
Volume 3 Year 308.78M
Range 10 Year
2.05 81.72
Volume 10 Year 416.65M

Highlights

Market Capitalization 4.46B (mid)
Floating Shares 47.88M
Current Price 64.97
Price To Earnings -101.53
Price To Revenue 73.61
Price To Book 12.8
Earnings Per Share -0.64
Payout Ratio 0%

Performance

Latest 0%
1 Month +0.7%
3 Months +108.64%
6 Months +383.05%
1 Year +583.89%
3 Years +333.13%
5 Years +997.47%
10 Years -1.56%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.